https://www.rhbtradesmart.com/smartpoints-faq.html

rhb*

then uses n2n. ta and cimb as well.

vole coming in. monitor

limit up tmr boom

next round coming.. their next quarter will be way better than the previous. they are not rakuten. u can't open within one day. mco started 18 March. opening other account like rhb cimb need at least 1 week. so they benefitted less in previous quarter.

hooting hlt

yes.. tmr need to queue d.. hope down limit up too fast

paktua investing in hlt. tmr boom time

looks like hlt boom tmr.. hahaha.. wtf.

looks like so many ppl hoot hlt.. gogogog

yea.. boss want to goreng for another month. kau lat..

hope no gap up then can accumulate

most likely they want to push up only announce the result d

yes. hlt haven't move much as compared to other glove stocks

HLT Current Price 57

HLT has gone unnoticed by the market that it has a subsidiary making rubber gloves with 1 bil pieces annual capacity which is similar to Rubberex and 25% of Careplus capacity.

HLT Global Berhad (“HLT”) is an investment holding company, whilst its two subsidiaries, HL Advance Technologies (M) Sdn Bhd (“HLA”) is in the business of fabrication of glove-dipping lines (“Glove-Dipping Lines Segment”) and HL Rubber Industries Sdn Bhd (“HLRI”) is in the business of manufacturing and trading of rubber gloves (“Rubber Gloves Segment”). Glove-Dipping Lines Segment HLA is principally involved in the following business activities:- (i) design, fabrication, installation, testing and commissioning of glove-dipping lines (“Sale of New Lines”); (ii) provision of upgrading and modification works for glove-dipping lines (“Upgrade and Modification”); and (iii) supply and trading of associated parts and components (“Supply and Trading”)

Rubber Gloves Segment HLT completed the acquisition of the 55% issued share capital of HLRI on 17 May 2018. HLRI commenced operations in 2003 and since its establishment it has proven track record on delivering quality products and services to its multinational customers. The rubber glove products include, amongst others, natural rubber gloves such as powdered and powder-free latex examination gloves, and synthetic rubber gloves such as powdered and powder-free nitrile examination gloves. Over the recent financial years, our products have been sold within Malaysia, and to other countries such as Taiwan, United States of America, Spain, Singapore, New Zealand, China and United Kingdom. In addition, HLRI is also certified to comply with the ISO 13485 : 2016 and EN ISO 13485 : 2016 requirements on medical devices quality management system for manufacture of non-sterile latex and nitrile examination gloves and ISO 9001 : 2015 requirements on quality management system for manufacture of non-sterile latex and nitrile examination gloves, both accredited by the United Kingdom Accreditation Service.
HLT is in the business of making dipping lines for the gloves industry ..... and they have just signed an exclusive licensing agreement on patented triple dipping glove manufacturing line. HLT also owned a 55% subsidiary HL Rubber Industries with production capacity of 1 billion piece per year. With such capacity at current ASP, we shall be seeing HLT turning in good profit

So, in line with the popularity of glove sector now, this stock had good potential.

For FYE 2019, the rubber gloves segment posted a revenue of RM90.673 million. For current year quarter, the rubber gloves segment delivered revenue of RM19.314 million, 44.03% lower than preceding year quarter. Export sales contributed 92.30% of the total revenue of rubber gloves segment. The export market mainly consists of Taiwan, Southeast Asia, United States of America and Spain. The rubber gloves segment recorded a gross profit of RM0.173 million with a gross profit margin of 0.90% as compared to a gross profit of RM2.067 million with gross profit margin of 5.99% in the preceding year quarter. For FYE 2019, the rubber gloves segment recorded gross profit of RM1.269 million with gross profit margin of 1.40% as compared to gross profit of RM2.131 million with gross profit margin of 2.71%. The rubber gloves segment recorded loss before taxation of RM1.086 million as compared to a profit before taxation of RM0.741 million in preceding year quarter. For FYE 2019, the rubber gloves segment recorded loss before taxation of RM2.290 million as compared to loss before taxation of RM0.370 million in the FYE 2018

With the increase in ASP it profits will quantum leap.

great article

$KLSE-REXIT

Theme: Passive Aggressive Mid to Long term Strategy

We came to notice rexit company last week based on their recent quarter result. At a glance the company have not move much since the last drop during March 18. Rexit with the unique business.

Business
Rexit offers integrated financial solution which covers general insurance, unit trust management system and legal practice management. in short, practically they offer company with a web based solutions to cater for front-liners (sales and marketing) agents.

1) e- cover - it's a web based solutions which provides an online system for insurance companies and their intermediaries. the business model is run by SaaS model which is pay per use.
2) e-ppa - enabling online unit trust investment through EPF. traditionally, alot of allocation are done manually or through agents meeting face to face and submitting their application in a hardcopy format. now this has been shifted to online application.
3) infoguardian - it is a work flow management system. this solutions provide an integrated workflow, case management and docent management system for financial and legal services.

Simple financials
1) net cash of of 14 million and zero debt company. defensive play.
2) sales revenue compounded annual growth of around 30% for the past 6 years.
3) Asset light model - asset (ppe) comprise of only 10% of the total asset.
4) Clean accounts. - only 300k in Goodwill as compare to most company such as green packet (7billion in Goodwill) and krono (100million in Goodwill). prudent management which will not give surprises (huge impairement losses).
5) profit margin of 30%.
6) Roe of 24%
7) dividend of 5%.
- without further looking into details, the company has a very clean balance sheet. if there is a scoring for it, it will have gotten 90/100 marks.

why its passive aggressive? we would expect that with mco being lifted and post covid, more businesses, agents, companies, mnc, individual, will adapt to online system and we have seen the growth in adaptability of the online system. the management of rexit is very prudent whereby they don't make aggressive acquisition or even manipulate the share price. which is why it makes the company look boring as retailers loves to gamble. in this case, they can't.

earnings projection. assuming they were to maintain eps of 1.10 cents next 2 quarters and improvement in business to 1.30 cents and pe of 14/15 it will give them a value of 72 cents which is 30% margin of safety. technology sector which demand only a 15 pe, will be quite safe. is it enough? at current economic situation, we would start placing some of our investment in more defensive yet there is room for growth counters. the further upside based on their current financials, they could have gone to main market anytime in the future. any proposal to go to main market will give a boost to the company.

disclaimer: this is not a buy or sell call but more towards sharing purposes.

add me too

queinggg

gogogo gap up time

careplus gogogo

tomorrow to continue.. monitor if break 90 cents.. 1 ringgit tp

agree.. glove to continue performing tmr.

thanks. gap up tmr..

Careplus (Current price 90 Sen - Buy on Weakness and Price Volume Movement)

The estimated Qtr EPS could be range from 2.05 Sen to 2.3 Sen. The estimated FY 2020 EPS could range from 8.2 Sen to 9.2 Sen.

At PE 12, ITS VALUATION COULD RANGE FROM 98.4 TO 110.
At PE 15, VALUATION COULD RANGGE FROM 123 TO 138

Consider to enter at 85 Sen

New Catalysts for higher upside of share price

• Completion of disposal of 50% equity interest in Careplus (M) S/B (CMSB), a wholly owned subsidiary to Ansell for RM 27.0 mil.

• Sale at 150% of the 50% Net Asset value of CMSB and realized a profit on disposal of about RM17.98mil which is about 3.07 Sen EPS in Q2 FY 2020.

• Net proceeds of cash RM28.5 mil coming to Careplus after netting of additional share capital of RM10.5 mil for reinvestment in CMSB for subscription of new shares for expansion in CAPEX and repayment by CMSB of inter co loan of 12 mil

• This capital expenditure includes the upgrading and modification of CMSB’s existing machinery and premises, such as the purchase of a set of automated surgical glove packing machines and the renovation of CMSB’s existing packing room to cater for the new products to be supplied to and sold to Ansell and its affiliates

• On completion will create a Joint Venture which represent a strategic partnership between Careplus and Ansell to grow and develop CMSB’s glove manufacturing business, premised on creating sustainable long-term growth, expanding portfolios and future business activities while realising synergies in the value of CMSB.

• to grow CMSB’s business, leveraging on the knowledge and cooperation of Ansell Group, one of the global players for glove manufacturing in the market.

• Turning CMSB around from loss making to profitable with new business

The current increase in top and bottom line coupled with above profit on disposal and the 50:50 joint venture arrangement with Ansell for surgical glove using Ansell technology which would be profitable.

Dow Jones up again..

Careplus (Current price 90 Sen - Buy on Weakness and Price Volume Movement)

The estimated Qtr EPS could be range from 2.05 Sen to 2.3 Sen. The estimated FY 2020 EPS could range from 8.2 Sen to 9.2 Sen.

At PE 12, ITS VALUATION COULD RANGE FROM 98.4 TO 110.
At PE 15, VALUATION COULD RANGGE FROM 123 TO 138

Consider to enter at 85 Sen

New Catalysts for higher upside of share price

• Completion of disposal of 50% equity interest in Careplus (M) S/B (CMSB), a wholly owned subsidiary to Ansell for RM 27.0 mil.

• Sale at 150% of the 50% Net Asset value of CMSB and realized a profit on disposal of about RM17.98mil which is about 3.07 Sen EPS in Q2 FY 2020.

• Net proceeds of cash RM28.5 mil coming to Careplus after netting of additional share capital of RM10.5 mil for reinvestment in CMSB for subscription of new shares for expansion in CAPEX and repayment by CMSB of inter co loan of 12 mil

• This capital expenditure includes the upgrading and modification of CMSB’s existing machinery and premises, such as the purchase of a set of automated surgical glove packing machines and the renovation of CMSB’s existing packing room to cater for the new products to be supplied to and sold to Ansell and its affiliates

• On completion will create a Joint Venture which represent a strategic partnership between Careplus and Ansell to grow and develop CMSB’s glove manufacturing business, premised on creating sustainable long-term growth, expanding portfolios and future business activities while realising synergies in the value of CMSB.

• to grow CMSB’s business, leveraging on the knowledge and cooperation of Ansell Group, one of the global players for glove manufacturing in the market.

• Turning CMSB around from loss making to profitable with new business

The current increase in top and bottom line coupled with above profit on disposal and the 50:50 joint venture arrangement with Ansell for surgical glove using Ansell technology which would be profitable.

if result good will gap up next day

buy and wait result la.. u think glove result will be bad meh.

m

n2n looking for m

Careplus (Current price 90 Sen - Buy on Weakness and Price Volume Movement)

The estimated Qtr EPS could be range from 2.05 Sen to 2.3 Sen. The estimated FY 2020 EPS could range from 8.2 Sen to 9.2 Sen.

At PE 12, ITS VALUATION COULD RANGE FROM 98.4 TO 110.
At PE 15, VALUATION COULD RANGGE FROM 123 TO 138

Consider to enter at 85 Sen

New Catalysts for higher upside of share price

• Completion of disposal of 50% equity interest in Careplus (M) S/B (CMSB), a wholly owned subsidiary to Ansell for RM 27.0 mil.

• Sale at 150% of the 50% Net Asset value of CMSB and realized a profit on disposal of about RM17.98mil which is about 3.07 Sen EPS in Q2 FY 2020.

• Net proceeds of cash RM28.5 mil coming to Careplus after netting of additional share capital of RM10.5 mil for reinvestment in CMSB for subscription of new shares for expansion in CAPEX and repayment by CMSB of inter co loan of 12 mil

• This capital expenditure includes the upgrading and modification of CMSB’s existing machinery and premises, such as the purchase of a set of automated surgical glove packing machines and the renovation of CMSB’s existing packing room to cater for the new products to be supplied to and sold to Ansell and its affiliates

• On completion will create a Joint Venture which represent a strategic partnership between Careplus and Ansell to grow and develop CMSB’s glove manufacturing business, premised on creating sustainable long-term growth, expanding portfolios and future business activities while realising synergies in the value of CMSB.

• to grow CMSB’s business, leveraging on the knowledge and cooperation of Ansell Group, one of the global players for glove manufacturing in the market.

• Turning CMSB around from loss making to profitable with new business

The current increase in top and bottom line coupled with above profit on disposal and the 50:50 joint venture arrangement with Ansell for surgical glove using Ansell technology which would be profitable.

Bpplas berhad

Bpplastic business mainly focus on flexible stretch film which uses resin type ldpe/lldpe. both resins comes from ethene. with the current fall in crude oil price and natural gas, it will at least be beneficial to the plastic industry. why plastic industry now? it may not be the right time but comparing all the plastic counter, and recently SLP berhad which reported their quarter, saw their revenue drop of drop about 10% as well as their profit margin. looking at how bpplastic managing their profit margin and net cash we can know that their company will benefit from the fall in crude oil and natural gas price.

bpplas balance sheet is as clean as a whistle. there are totally no debt and net cash of 30 cents. seriously. today they liquidate everything, they still got 30 cents to pay back their shareholders. what I like about the company is that their inventory tend to fall in tandem with revenue. it's a good trend. meaning they are not keeping too much of previous inventory. otherwise, they will have to do lots of impairment.

Assuming next quarter profit were to drop by at least 50% next two quarters, will give them eps of 1.50 cents. 3.32 cents 1.50 cents 1.50 eps 3 eps. conservatively with 15 or it will give them a valuation of about 1.40. margin of safety is 40%. In addition, they are even declaring with 2 cents dividend. if they maintain their dividend which I expect they will due to net cash company, it will give them around 6% dividend yield.

Plastic usage expects to rise in the near future as well due to the use of more electronic devices, more people are taking away their food compare to eating in, rising demand in frozen food. many might say what if there is a rise in oil price? it won't happen in the next 2/3 years. based on the current usage and US being the largest oil producer which they will not stop the fracking process (uses to dig out shale oil), the oversupply of oil in the next few years. plastic industry will be a safe bet in a fundamental portfolio.

disclaimer: it's not a recommendation buy call but more towards knowledge and sharing purposes.


$KLSE-BPPLAS

agree. cut and buy at 60 cents.

hammer form. reversal sign.

today red sea sapu. if can take profit and run d. buy later.

doesn't matter. reversal coming. if possible take profit.

surging to drop

don't say bo jio.. break strong resistance at 71/72 d

boleh. depending. this share net cash.. the more u trade, u giving them service money. lol. isn't it obvious they are making money.

70 cents soon.

Nova comingg

don't forget nova wellness

agreee..

change ship to nova wellness d

agree. how many bursa company net cash 10 cents. but one must know how this industry work. look at ysp. this kind of industry will never die. u thinktauke buy 55 cents 10 cents run meh.

Nova wellness safer.

quite expensive can't buy much lot. go for nova wellness better.

agree. investors buying blindly man. one day bubble burst. go for net cash company guys.